Psoriasis treatments are transforming lives

It’s a confusing time to be a psoriasis patient. If you watch TV, you are seeing a record number of advertisements about various psoriasis and psoriatic arthritis treatments. Meanwhile, worldwide media phenomenon Kim Kardashian is posting on Instagram about weird potions she is drinking, and applying to her face, to try to control her psoriasis; while on her TV show, she sought treatment advice from a quack who has made a mint pretending to “commune” with “spirits” to heal incurable diseases. Not be outdone, internet message boards, YouTube videos, and the media are overflowing with stories about the latest fad ingredient that will most definitely, certainly, “CURE” your psoriasis. Spoiler alert: it won’t.

What can get lost in this clamor is the most exciting psoriasis news in decades – and perhaps ever. For the first time, clear skin is within reach for many people living with moderate to severe plaque psoriasis, and stopping disease progression is within reach for most people with active psoriatic arthritis.

This is phenomenal and should give every person with psoriasis or psoriatic arthritis hope, and inspire them to see a dermatologist (a doctor who specializes in treating diseases related to the skin), or a rheumatologist (a doctor who specializes in joint disease), and investigate all the promising treatment options.

This progress has been driven by scientific and medical advances that have greatly expanded our understanding of the immune system’s role in psoriatic disease. This, in turn, has led to targeted therapies that have improved both safety and effectiveness over treatments available a generation ago. Today, for many people with psoriasis, 90% or more improvement of their skin symptoms is within reach; and some are achieving completely clear skin that can be maintained safely for years.

This. Is. Monumental.

Choose your path to learn more….

The Latest Psoriasis News

“Fail first” insurance mandates not just a problem for U.S. psoriasis patients

“Fail first” policies are one of the mandates imposed by some U.S. health insurers to reduce their costs. They require that people with psoriasis (and other serious diseases) try older and inferior – and often less safe – treatments before they can access the 21st century treatments that work best. Continue Reading…

Imagine knowing after 4 weeks, how a new psoriasis treatment would be working for you after 6 months…

Here’s an interesting, after-the-fact analysis from clinical trials of the biologic Ilumya (tildrakizumab-asmn), an “IL-23 inhibitor” marketed by Sun Pharma. The researchers looked at psoriasis severity scores used in clinical trials, known as PASI scores (Psoriasis Area and Severity Index), for each patient. Each patient’s score is determined before the Continue Reading…

Opioid use “substantial” among people with moderate to severe psoriasis

A recent study looked at a database of privately insured people that included about 9,000 psoriasis patients, of whom just over 2,000 were identified as having moderate to severe psoriasis. It found that about 25% of those 2,000 received opioids, compared to 16% of otherwise-comparable people without psoriasis. The figure Continue Reading…

Join the Battle